8VA6
 
 | | Menin in complex with Ziftomenib (KO-539) | | Descriptor: | 1,2-ETHANEDIOL, DI(HYDROXYETHYL)ETHER, DIMETHYL SULFOXIDE, ... | | Authors: | Clegg, B.D, Linhares, B.M, Cierpicki, T, Grembecka, J. | | Deposit date: | 2023-12-11 | | Release date: | 2024-11-20 | | Last modified: | 2025-06-04 | | Method: | X-RAY DIFFRACTION (1.57 Å) | | Cite: | Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial.
Lancet Oncol, 25, 2024
|
|
8VA5
 | | Menin mutant - T349M in complex with Ziftomenib (KO-539) | | Descriptor: | 1,2-ETHANEDIOL, DI(HYDROXYETHYL)ETHER, DIMETHYL SULFOXIDE, ... | | Authors: | Clegg, B.D, Cierpicki, T, Grembecka, J. | | Deposit date: | 2023-12-11 | | Release date: | 2024-11-20 | | Last modified: | 2025-06-04 | | Method: | X-RAY DIFFRACTION (1.3 Å) | | Cite: | Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial.
Lancet Oncol, 25, 2024
|
|
